Zelira Therapeutics: Raises $1.77m through US-based investors

Zelira Therapeutics Raises $1.77m through US-based investors

• Zelira Therapeutics (ZLD) raises $1.77 million to progress its clinical trials
• The funds were raised via a placement to US-based investors at $1 per share, representing a 3 per cent discount to ZLD’s 15-day VWAP on March 10
• Zelira says the money will be used to further progress its ongoing strategies of “multiple shots on goal” for its proprietary formulations through clinical trials
• Settlement of the shares is expected to occur on March 17
• ZeliraTherapeutics is up 8 per cent, trading at $1.08 at 2:03 pm AEDT